Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
Clinical trial NCT00004941 · COMPLETED
Trial details
- NCT number
- NCT00004941
- Sponsor
- FDA Office of Orphan Products Development
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1996-07-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.